ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer
Neoplasm Metastasis

Breast Cancer trials near Tampa, FL, USA:

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...

Enrolling
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Capecitabine
Drug: PCS6422 and capecitabine

Phase 2

Processa Pharmaceuticals

Tampa, Florida, United States and 11 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

Tampa, Florida, United States and 7 other locations

A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...

Enrolling
Breast Cancer Stage IV
Breast Cancer
Drug: MBQ-167

Phase 1

MBQ Pharma

Sarasota, Florida, United States and 3 other locations

This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer...

Enrolling
Breast Cancer Female
Device: Breast Cancer Locator (BCL) guided partial mastectomy
Device: Wire Localized (WL) partial mastectomy
CairnSurgical

Tampa, Florida, United States and 25 other locations

as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study is studying the safety, tol...

Active, not recruiting
Breast Cancer
Biological: PVX-410
Biological: Durvalumab

Phase 1

Mass General Brigham
Mass General Brigham

Tampa, Florida, United States and 4 other locations

The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant

Active, not recruiting
Advanced Metastatic Breast Cancer
Drug: AZD2014
Drug: Fulvestrant

Phase 1

AstraZeneca
AstraZeneca

Sarasota, Florida, United States and 4 other locations

and efficacy of the oral chemotherapy capecitabine in combination with cemiplimab in patients with hormone-receptor-positive (HR+) metastatic breast...

Active, not recruiting
Hormone Receptor-positive Breast Cancer
Drug: Capecitabine
Drug: Cemiplimab

Phase 1

H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Enrolling
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Clearwater, Florida, United States and 33 other locations

(a modified herpes simplex 1 virus that can specifically destroy cancer cells while leaving normal cells alone) injected directly into the t ...

Active, not recruiting
Invasive Breast Carcinoma
Breast Cancer
Biological: Talimogene laherparepvec
Drug: Paclitaxel

Phase 1, Phase 2

H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Sarasota, Florida, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems